STRATA Skin Sciences, Inc. - GlobeNewswire - Mon May 18, 7:30AM CDT HORSHAM, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”), a global leader in excimer ...
STRATA Skin Sciences announces a study validating its Excimer Laser technology's superiority in treating dermatological conditions compared to traditional UVB sources. STRATA Skin Sciences, Inc.
HORSHAM, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and ...
A 12-month real-world cohort (n=500) showed statistically significant VASI reductions across all treatments, with NB-UVB and JAK inhibitor monotherapies outperforming TCS/TCI alone. Combination ...
Dr Dunn leads a discussion outlining frontline therapies for the treatment of vitiligo. Jeffrey D. Dunn, PharmD, MBA: What therapies are being used? Are they generally covered by different books of ...
Credit: Getty Images The Vitiligo Task Force developed expert-based recommendations for the treatment of vitiligo, worldwide. The International Vitiligo Task Force has issued up-to-date evidence-based ...
HORSHAM, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”), a global leader in excimer laser therapy dedicated to developing, commercializing, and marketing ...
Multicenter prospective RCT published in JAAD confirms superiority of XTRAC® Excimer Laser plus oral JAK inhibitors over tacrolimus combination therapy in children aged 2-18 years with progressive ...
(MENAFN- GlobeNewsWire - Nasdaq) Multicenter prospective RCT published in JAAD confirms superiority of XTRAC® Excimer Laser plus oral JAK inhibitors over tacrolimus combination therapy in children ...